A multidisciplinary, virtual platform showed preliminary feasibility for reducing distress and improving access for patients ...
Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback